Neogenomics

$Neogenomics(NEO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-117732  Act: 34  Size: 15 KB 网页链接

AI查询结果，作为备忘录保存下来，仅供参考。
1. 脊髓损伤市场空间
患者规模：
中国现存脊髓损伤患者约374万人，每年新增患者约9万人[citation:1][citation:2]
全球脊髓损伤患者数量已突破2700万，并以年均12.3%的增长率持续攀升[citation:5]
市场规模：
2023年中国脊髓损...

$Neogenomics(NEO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001077183-25-000172  Act: 34  Size: 705 KB 网页链接

$Neogenomics(NEO)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0002012383-25-002433  Act: 34  Size: 11 KB 网页链接

$Neogenomics(NEO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-009358  Act: 33  Size: 6 KB 网页链接

$Neogenomics(NEO)$ Millennium Management LLC连同Millennium Group Management LLC和Israel A. Englander提交了13G表格，披露持有NeoGenomics, Inc.普通股5%的所有权。该文件报告截至2025年12月2日持有6,483,428股，较之前持有的6,436,776股（4.97%所有权）有所增加。这些投资实体均位于纽约，对...

$Neogenomics(NEO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-008029  Act: 33  Size: 4 KB 网页链接

$Neogenomics(NEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-045529  Size: 27 KB 网页链接

$Neogenomics(NEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-054270  Size: 29 KB 网页链接

$Neogenomics(NEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-056080  Size: 20 KB 网页链接

$Neogenomics(NEO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001077183-25-000175  Act: 34  Size: 7 MB 网页链接

$Neogenomics(NEO)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-119674  Act: 34  Size: 15 KB 网页链接

$Neogenomics(NEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-055121  Size: 28 KB 网页链接